Craft

Blirt

Revenue

ZŁ39.8 M

FY, 2021

Blirt Summary

Company Summary

Overview
BLIRT (Biolab Innovative Research Technologies) is a biotech manufacturer of proteins, enzymes, and molecular biology reagents. It offers products such as proteinase K, RNase inhibitor, polymerases, nucleases, ligases, etc. The company also provides kits for nucleic acid isolation, reverse transcription tools, electrophoresis products, and real-time PCR reagents. BLIRT serves scientists and researchers engaged in the health and life science sectors.
Type
Public
Status
Active
Founded
1994
HQ
Gdańsk, PL | view all locations
Website
https://blirt.eu/
Cybersecurity rating
Sectors

Key People

  • Thierry Bernard, Chief Executive Officer

    • Krzysztof Kur

      Krzysztof Kur, Member of the Managing Board, R&D

    • Aleksandra Kukiełło

      Aleksandra Kukiełło, Chief Business Support Officer

    • Tomasz Wrzesinski

      Tomasz Wrzesinski, Member of the Managing Board

    Operating MetricsView all

    Distributors

    26

    Jan, 2021

    Product Lines

    5

    Jan, 2021

    Facilities

    3

    Jan, 2021

    LocationsView all

    2 locations detected

    • Gdańsk, Pomorskie HQ

      Poland

      Trzy Lipy 1

    • Gdańsk, Pomorskie

      Poland

      Kładki 24/93

    Blirt Financials

    Summary Financials

    Revenue (Q2, 2022)
    zł5.1M
    Gross profit (Q2, 2022)
    zł4.6M
    Net income (Q2, 2022)
    zł934.0K
    Cash (Q2, 2022)
    zł4.9M
    EBIT (Q2, 2022)
    zł1.4M

    Footer menu